Published in

Journal of Cutaneous Immunology and Allergy, 6(6), p. 262-263, 2023

DOI: 10.1002/cia2.12333

Links

Tools

Export citation

Search in Google Scholar

Effectiveness of upadacitinib in Japanese patients with prurigo‐type atopic dermatitis: Four cases report

Journal article published in 2023 by Keiji Kosaka ORCID, Akihiko Uchiyama ORCID, Mai Ishikawa, Sei‐ichiro Motegi ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

We present four Japanese patients with prurigo‐type AD who received upadacitinib. Rapid improvement of skin lesions and itchiness was seen in all patients. Janus kinase inhibitor is effective for prurigo‐type AD by strongly suppressing itching.